Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 2411-2420 of 2876 for cancer

Edit search filters
  1. A Study to Assess Tissue Mechanical Properties as a Prognostic Biomarker of Breast Cancer using MR Elastography

  2. A Study To Find New Family Linked Forms Of Kidney Cancer

    Jacksonville, FL, Rochester, MN

  3. Chemotherapy Toxicity On Quality of Life in Older Patients with Stage I, Stage II, Stage III, or Stage IV Ovarian Epithelial, Primary Peritoneal Cavity, or Fallopian Tube Cancer

    Scottsdale/Phoenix, AZ, Rochester, MN

  4. Comparing The Investigational Imaging System With Sonography

    Rochester, MN

  5. Study Using Chromogranin A As Surveillance Biomarker In Patients With CARcinoids

    Rochester, MN

  6. A Study to Compare Outcomes of Patients Who Underwent Open and Robotic Prostatectomy for Prostate Cancer

    Rochester, MN

  7. A Study To Identify Biomarkers In The Blood, Saliva Or Tissue For Oropharyngeal Squamous Cell Cancer

    Rochester, MN

  8. Cytotoxic Activity of Lenalidomide in Combination with the Bispecific CD30/CD16a Therapeutic Monoclonal Antibody, AFM13

    Jacksonville, FL

  9. A Study to Evaluate Fallopian Tube Serous Tubal In Situ Carcinoma Lesions

    Jacksonville, FL, Rochester, MN

  10. Quality-Adjusted Survival in Allogeneic Hematopoietic Cell Transplant Patients

    Rochester, MN

.

Mayo Clinic Footer